Bila Solar has started module production in Indiana and T1 Energy is preparing to build a 5 gigawatt, $850M solar cell ...

Australian manganese producer Element 25 said on Tuesday the Northern Australia Infrastructure Facility (NAIF) has agreed to provide a senior debt facility of up to A$50 million ($32.57 million) for ...

Eli Lilly is in advanced talks to acquire gene editing startup Verve Therapeutics for up to $1.3 billion, the Financial Times reported on Monday, citing people familiar with the matter.

Amid a spate of high-profile investments in U.S. pharmaceutical production, two contract manufacturers are getting in on the ...

While some compounding pharmacies have stopped making alternatives to Wegovy and Zepbound since shortages were declared over, ...

Bila Solar is manufacturing ultra-lightweight solar modules and newly launched 550 W dual-glass conventional panels in its ...

Behind-the-scenes video captures this milestone for American solar - creating local jobs and reinforcing why federal support ...

In today's Pharmalittle roundup, we're reading about a Sarepta setback with its Duchenne drug, the FDA workload causing a ...

Bila Solar has begun producing its new line of silicon solar panels at its Indianapolis factory, the company announced. “This ...

Eli Lilly's drug, called eloralintide, helped some patients lose more than 11% of their body weight in three months.